DCE-MRI定量与定性参数预测胶质瘤CDKN2A/B纯合缺失
回顾性纳入105例胶质瘤患者术前MRI,其中69例无CDKN2A/B纯合缺失、36例有纯合缺失,分析常规MRI特征及DCE-MRI定性参数TIC类型与定量参数Ktrans、Kep、Ve、Vp、iAUC。多因素分析显示年龄(OR=1.103,p=0.002)与Ktrans(OR=1.051,p<0.001)独立预测CDKN2A/B纯合缺失,全组、IDH突变型及IDH野生型模型AUC分别为0.90、0.95和0.84。
要点
- Ktrans在全部胶质瘤及IDH突变型、IDH野生型亚型中均为CDKN2A/B纯合缺失的独立预测因子。
- 全组、IDH突变型、IDH野生型预测模型AUC分别为0.90、0.95、0.84。
- 年龄是全组及IDH野生型亚组的独立预测因子,IDH突变型亚组仅Ktrans为独立预测因子。
核心结论
- Ktrans可作为识别全部类型胶质瘤及IDH突变型、IDH野生型亚型中CDKN2A/B纯合缺失状态的有价值预测参数,为胶质瘤患者术前无创精准诊断与个体化治疗提供基础。
研究设计与样本
- 回顾性收集105例胶质瘤患者术前MRI数据,其中69例无CDKN2A/B纯合缺失、36例有CDKN2A/B纯合缺失,获取常规MRI特征及DCE-MRI定性参数TIC类型和定量参数Ktrans、Kep、Ve、Vp、iAUC,在全部胶质瘤及IDH突变型、IDH野生型亚组中构建预测CDKN2A/B纯合缺失状态的逻辑回归模型。
诊断标准与关键数值
- 全部患者多因素分析:年龄OR=1.103(p=0.002)、Ktrans OR=1.051(p<0.001)独立预测CDKN2A/B纯合缺失。
- IDH突变型亚组多因素分析:Ktrans OR=1.098(p=0.031)为CDKN2A/B纯合缺失的独立预测因子。
- IDH野生型亚组多因素分析:年龄OR=1.111(p=0.002)、Ktrans OR=1.032(p=0.001)为CDKN2A/B纯合缺失的独立预测因子。
- 全部患者、IDH突变型亚组、IDH野生型亚组对应模型ROC曲线下面积分别为0.90、0.95、0.84。
临床应用与阅片要点
- 作者认为Ktrans可作为识别全部类型胶质瘤及IDH突变型、IDH野生型亚型中CDKN2A/B纯合缺失状态的有价值预测参数。
- 作者认为这些发现为胶质瘤患者术前无创精准诊断和个体化治疗提供了基础。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Homozygous deletion (HD) of CDKN2A/B holds important prognostic value in gliomas. This study aimed to explore the predictive potential of conventional MRI characteristics combined with dynamic contrast-enhanced MRI parameters in predicting CDKN2A/B HD status in gliomas.
MATERIALS AND METHODS: Preoperative MRI data of 105 patients (69 without CDKN2A/B HD, and 36 with CDKN2A/B homozygous deletion) with gliomas were retrospectively collected. Conventional MRI features and dynamic contrast-enhanced-MRI qualitative parameter time-intensity curve type, quantitative parameters Ktrans, Kep, Ve, Vp, and iAUC were obtained. Logistic regression models for prediction of CDKN2A/B HD status were constructed in all types of gliomas and both subtypes of IDH-mutant and IDH-wild gliomas.
RESULTS: Multivariate analysis for all patients demonstrated that age (OR=1.103, p = 0.002) and Ktrans (OR=1.051, p < 0.001) independently predicted CDKN2A/B HD. In IDH-mutant subgroup, multivariate analysis results indicated that Ktrans (OR=1.098, p = 0.031) emerged as autonomous predictors of CDKN2A/B HD. In IDH-wild subgroup, age (OR=1.111, p = 0.002) and Ktrans (OR=1.032, p = 0.001) were independent predictors of CDKN2A/B HD according to the multivariate analysis. The areas under the receiver operating characteristic curve of the corresponding models were 0.90, 0.95 and 0.84, respectively.
CONCLUSION: Ktrans can serve as valuable predictive parameters for identifying CDKN2A/B HD status in all types of gliomas and both subtypes of IDH-mutant and IDH-wild gliomas. These findings provide a foundation for precise preoperative non-invasive diagnosis and personalized treatment approaches for glioma patients.
引用
- Yang H, Zhu Z, Long C, et al. Quantitative and Qualitative Parameters of DCE-MRI Predict CDKN2A/B Homozygous Deletion in Gliomas. Acad Radiol. 2024. PMID: 38443208. doi:10.1016/j.acra.2024.02.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。